For: | Çeneli &, Özkurt ZN, Acar K, Rota S, Akı ŞZ, Yeğin ZA, Yağcı M, Özenirler S, Sucak GT. Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients. World J Gastroenterol 2010; 16(14): 1765-1771 [PMID: 20380010 DOI: 10.3748/wjg.v16.i14.1765] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i14/1765.htm |
Number | Citing Articles |
1 |
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu. Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers 2019; 11(11): 1819 doi: 10.3390/cancers11111819
|
2 |
Jaime Morales-Romero, Gustavo Vargas, Rebeca García-Román. Occult HBV Infection: A Faceless Enemy in Liver Cancer Development. Viruses 2014; 6(4): 1590 doi: 10.3390/v6041590
|
3 |
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients. International Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
|
4 |
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and Management. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
|
5 |
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis. International Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
|
6 |
Katsumasa Kobayashi, Toshiro Kamoshida, Motoko Ono, Yumiko Ota, Atsushi Okawara, Nobushige Kakinoki, Mitsuoki Nijima, Akihisa Ishikawa, Shinji Hirai, Daisuke Kudo, Yuriko Monma, Norio Chikatsu, Atsushi Shinagawa, Yuji Oka. A case of de novo hepatitis B developed after 24 months later from autologous peripheral blood cell transplantation. Kanzo 2011; 52(9): 602 doi: 10.2957/kanzo.52.602
|
7 |
Merih Kızıl Çakar, Elif Suyanı, Gülsan Türköz Sucak, Şermin Altındal, Şahika Zeynep Akı, Kadir Acar, Münci Yağcı, Seyyal Rota, Seren Özenirler. HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey. Annals of Hematology 2013; 92(3): 395 doi: 10.1007/s00277-012-1620-1
|
8 |
Wei Liu, Yuanyuan Xie, Tianyun Gao, Feifei Huang, Liudi Wang, Lijun Ding, Wenqing Wang, Shuo Liu, Jianwu Dai, Bin Wang. Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products. Stem Cell Research & Therapy 2018; 9(1) doi: 10.1186/s13287-018-0920-3
|
9 |
Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, Atsushi Isoda, Morio Matsumoto, Michiaki Koike, Hideto Tamura, Keiichi Moriya, Shigeki Ito, Maki Asahi, Yoichi Imai, Junji Tanaka, Hiroshi Handa, Hiromi Koiso, Sakae Tanosaki, Jian Hua, Masao Hagihara, Yuriko Yahata, Satoko Suzuki, Sumio Watanabe, Hiroki Sugimori, Norio Komatsu. Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents’ era. Annals of Hematology 2016; 95(9): 1465 doi: 10.1007/s00277-016-2742-7
|
10 |
Maurizio Pompili, Maria Basso, Stefan Hohaus, Giulia Bosco, Lorenzo Nosotti, Mariella D’Andrea, Susanna Fenu, Antonio Grieco, Luca Laurenti, Concetta Mirisola, Livio Pagano, Gian Ludovico Rapaccini, Simona Sica, Sergio Storti, Raffaele Landolfi. Prospective study of hepatitis B virus reactivation in patients with hematological malignancies. Annals of Hepatology 2015; 14(2): 168 doi: 10.1016/S1665-2681(19)30778-1
|
11 |
|
12 |
Soheil Tavakolpour, Seyed Moayed Alavian, Shahnaz Sali. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.35810
|
13 |
Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila. Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis. Critical Reviews in Oncology/Hematology 2013; 87(1): 12 doi: 10.1016/j.critrevonc.2012.12.004
|
14 |
|
15 |
Hyunsung Park, Do Young Kim, Soo-Jeong Kim, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jae-Woo Song, Jin Seok Kim. HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma. Cancer Research and Treatment 2018; 50(4): 1121 doi: 10.4143/crt.2017.329
|
16 |
Wai-Kay Seto. Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification. World Journal of Hepatology 2015; 7(6): 825-830 doi: 10.4254/wjh.v7.i6.825
|
17 |
Panagiotis Papamichalis, Alexis Alexiou, Maria Boulbou, George N. Dalekos, Eirini I. Rigopoulou. Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(1): 84 doi: 10.1016/j.clinre.2011.07.018
|
18 |
Hwi Young Kim, Won Kim. Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013. World Journal of Gastroenterology 2014; 20(40): 14581-14588 doi: 10.3748/wjg.v20.i40.14581
|